Using dual checkpoint blockade to treat fibrolamellar hepatocellular carcinoma | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

PostScript

Letter

Using dual checkpoint blockade to treat fibrolamellar hepatocellular carcinoma

Online download statistics by month:

Online download statistics by month: February 2020 to March 2024

	Abstract	Full	Pdf
Feb 2020	756	43	26
Mar 2020	601	28	8
Apr 2020	120	19	12
May 2020	74	7	2
Jun 2020	93	9	5
Jul 2020	154	9	8
Aug 2020	59	6	7
Sep 2020	125	15	11
Oct 2020	422	29	19
Nov 2020	134	9	6
Dec 2020	156	25	12
Jan 2021	153	8	4
Feb 2021	106	8	6
Mar 2021	186	21	22
Apr 2021	154	10	9
May 2021	51	9	7
Jun 2021	9	6	0
Jul 2021	18	11	6
Aug 2021	17	13	3
Sep 2021	14	5	4
Oct 2021	73	8	3
Nov 2021	133	13	4
Dec 2021	125	3	4
Jan 2022	173	7	4
Feb 2022	52	2	3
Mar 2022	88	11	4
Apr 2022	79	6	4
May 2022	64	0	2
Jun 2022	90	4	0
Jul 2022	132	12	1
Aug 2022	209	16	11
Sep 2022	143	10	5
Oct 2022	170	13	5
Nov 2022	59	6	3
Dec 2022	137	9	3
Jan 2023	59	6	3
Feb 2023	94	5	6
Mar 2023	86	2	3
Apr 2023	63	4	1
May 2023	89	7	4
Jun 2023	59	5	3
Jul 2023	27	2	1
Aug 2023	21	1	0
Sep 2023	26	2	1
Oct 2023	30	1	0
Nov 2023	99	2	1
Dec 2023	32	3	0
Jan 2024	42	6	1
Feb 2024	22	3	0
Mar 2024	32	2	2
Total	5910	461	259